Novel and Rare Fusion Transcripts Involving Transcription Factors and Tumor Suppressor Genes in Acute Myeloid Leukemia
Antonella Padella(University of Bologna), Giovanni Martinelli(University of Bologna), Simona Soverini(University of Bologna), Anna Ferrari(University of Bologna), George Giotopoulos(Wellcome/MRC Cambridge Stem Cell Institute), Andrea Ghelli Luserna di Rorà(Fondazione Pisa), Maria Chiara Fontana(Istituto Oncologico Romagnolo), Claudia Haferlach(Munich Leukemia Laboratory (Germany)), Emanuela Ottaviani(University of Bologna), Martina Ghetti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Brian J.P. Huntly(Wellcome/MRC Cambridge Stem Cell Institute), Eugenia Franchini(University of Bologna), Cristina Papayannidis(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Clelia Tiziana Storlazzi(University of Bari Aldo Moro), Giorgia Simonetti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Elena Sabattini(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Ilaria Iacobucci(St. Jude Children's Research Hospital), Nicoletta Testoni(Thrombolysis in Myocardial Infarction Study Group), Viviana Guadagnuolo(University of Bologna), Elisa Ficarra(Politecnico di Torino), Simona Righi(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Carmen Baldazzi(University of Bologna), Giulia Paciello(Politecnico di Torino), Samantha Bruno(University of Bologna), Rossella De Tommaso(University of Bologna), Anna Stengel(Munich Leukemia Laboratory (Germany)), Valentina Robustelli(University of Bologna)
Cited by 24
Related Papers
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
|Nature|2011|1.5k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k